May 17, 2023

A Passion for Helping Others Leads to a Career in Pathology

Born and raised in Northeast China, Dr. Xinna Li, Assistant Research Scientist in the Department of Pathology, has always been passionate about helping others. Her journey began with a childhood fascination with medicine. “I remember as a very young child, bandaging a cut on my brother’s leg. Then, as a teen, my cousin became very ill and I observed how medical treatment could cure illnesses. That is when I realized that I wanted to be a doctor,” recounted Li. Driven by the desire to make a difference, she pursued a medical degree in pediatric hematology from China Medical graduating in 1994.

Events General News
May 17, 2023

A Passion for Helping Others Leads to a Career in Pathology

Born and raised in Northeast China, Dr. Xinna Li, Assistant Research Scientist in the Department of Pathology, has always been passionate about helping others. Her journey began with a childhood fascination with medicine. “I remember as a very young child, bandaging a cut on my brother’s leg. Then, as a teen, my cousin became very ill and I observed how medical treatment could cure illnesses. That is when I realized that I wanted to be a doctor,” recounted Li. Driven by the desire to make a difference, she pursued a medical degree in pediatric hematology from China Medical graduating in 1994.

Events General News
April 6, 2023

New Antibody Treatment Discovered by Ward Lab Approved by FDA

After several decades of hard work by many scientists at the University of Michigan Medical School and elsewhere, an antibody (anti-C5a) has just been approved by the US FDA for treatment of humans who are septic and have developed lung infections with COVID-19, resulting in severe pulmonary dysfunction requiring external lung support. The antibody, anti-C5a, was originally developed in the Dr. Peter Ward laboratory in the early 2000s. The mAb was shown to dramatically reduce lung infections in polymicrobial sepsis in mice. 

Events General News
April 5, 2023

Idiopathic Pulmonary Fibrosis Research Discovery Published

Idiopathic Pulmonary Fibrosis (IPF) is a disease with unknown causes that result in scarring of the lungs. The scar tissue forms on the alveoli, the small air sacs in the lungs, which makes it more difficult for oxygen to pass through the alveoli walls and into the bloodstream and for carbon dioxide to be removed.

All News Events
January 18, 2023

Study Published on Effectiveness of the Omicron Bivalent Booster

As the SARS-CoV-2 virus continues to mutate over time and new booster vaccines become available, the question arises, are the multivalent boosters more effective at improving immune response than the monovalent vaccines with which we began? This question was addressed by a multi-site group from Columbia University Vagelos College of Physicians and Surgeons (New York) and from the University of Michigan Medical School Department of Pathology.

All News Scientific and Clinical Research
January 13, 2023

The American Board of Pathology Announces the Appointment of May Chan, MD to the Test Development and Advisory Committee for Dermatopathology

The Department of Pathology offers its congratulations to Dr. May Chan, Professor of Dermatopathology, on her appointment to the American Board of Pathology's Test Development and Advisory Committee beginning in 2023. "As an established subject matter expert in dermatopathology, the contributions of Dr. Chan will be highly valued," commented Bonnie Woodworth, ABP Communications Director. Chan, who also serves as the Program Director for the Dermatopathology Fellowship Program, commented, "With this appointment, I’ll be joining seven esteemed dermatopathologists in designing and writing questions for the dermpath board exam and for the dermpath portion of the anatomic pathology board exam.

All News General News